3 Recruiting Ovarian Cancer Recurrent Phase 1 Clinical Trials

Active phase 1 studies for ovarian cancer recurrent enrolling across the USA. Verify eligibility and contact site coordinators.

All Ovarian Cancer Recurrent studies

Phase 1 Studies for Ovarian Cancer Recurrent

🔵 Active, Not Recruiting Phase1 / Phase2

Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer

📍 Magee-Womens Hospital of UPMC — Pittsburgh, Pennsylvania

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

📍 Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0019) — New Haven, Connecticut

View Study & Checklist ➔

🟢 Recruiting Phase1

A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

📍 Karmanos Cancer Institute — Detroit, Michigan

View Study & Checklist ➔